US Congressman Discloses XRP, SOL, and BTC Holdings

Rep. Guy Reschenthaler (R-Pa) recently disclosed various cryptocurrency purchases.

The 41-year-old US lawmaker now owns such cryptocurrencies as Ripple-linked XRP, Solana and Bitcoin. All of these purchases were in the range of $1,000-$15,000.

Mike Collins (R-Ga) also disclosed a purchase of Ski Mask Dog (SKI) earlier this year.

Barry Moore (R-Al) and Jeffrey Jackson (D-NC) are also among the U.S. lawmakers who previously reported significant cryptocurrency transactions.

Back in 2021, the Wall Street Journal reported that a total of 11 members of Congress were cryptocurrency holders, with nine of them being House representatives.

In the meantime, the U.S. Senate will have a committee specifically dedicated to digital assets.

This committee will be spearheaded by Sen. Cynthia Lummis (R-Wyo.), who famously came up with a bill that would require the Treasury to purchase a whopping 1 million Bitcoins over the course of five years.

The 70-year-old senator previously claimed that she had bought Bitcoin for the first time back in 2013. She later disclosed another purchase in 2021.

The U.S. House Ethics Committee issued a memo that required House members to disclose cryptocurrency holdings exceeding $1,000 back in 2018. Prior to that, the cryptocurrency transactions of U.S. lawmakers were unknown since the disclosure rules for stocks and bonds did not include the newfangled asset class.

Such legally mandated disclosed are necessary to see whether lawmakers have skin in the game.

Sen. Elizabeth Warren (D-Mass) recently opined that crypto investing represented "a terrible conflict of interest" for lawmakers, and she was glad that the number of members of Congress who hold crypto was relatively low.

Comments

Pages

Archive

Show more

Popular posts from this blog

Top 10 ETF Picks for August 2025: Best Funds to Buy Now for Growth, Safety, and Diversification

Best Gold and Silver ETFs of 2025: Should You Buy Today?

Top Gold ETFs to Watch in 2025: Best Picks for Strong Returns and Low Costs

Top 10 Pharma Companies by Market Cap in 2025

Top XRP ETFs to Watch in 2025: Dominating Holdings, Low Fees, and Performance Insights

Top 10 Pharmaceutical Companies by Revenue in 2025 (July Edition)

Top 10 Cancer Drug Companies of 2025

Top 10 Credit Cards for Hospital Bills in Singapore 2025

Did Steve Jobs Refuse Treatment for Pancreatic Cancer?

Top 10 Stocks Poised to Outperform in August 2025: AI, Clean Energy, and Tech Leaders to Watch